News for April 2015

News Archive

World Drug Safety Conference hears call for wider use of cognitive safety testing in drug development World Drug Safety Conference hears call for wider use of cognitive safety testing in drug development

In a call to the pharmaceutical industry at the World Drug Safety Conference in Chicago last week (April 22-23 2015), a leading developer of cognitive assessment software, Cambridge Cognition plc, stressed the increasing regulatory and clinical need to expand cognitive safety testing beyond CNS-targeted drugs.

The Current issue of “The view from here” discusses novel therapeutics. The Current issue of “The view from here” discusses novel therapeutics.

The topic of this month’s newsletter from Drug Discovery Today is novel therapeutics.

Our ancestors could hold the key to early diagnosis of bone disease Our ancestors could hold the key to early diagnosis of bone disease

The UK has the highest rate of Paget’s bone disease in the world, but now researchers from Liverpool John Moores University (LJMU), the Paget’s Association and Norton Priory Museum Trust are analysing ancient bones to better understand the progression of the disease, which may permit earlier diagnosis.

Nature Communications Publications on the First X-ray Crystal Structures of Spiegelmers Bound to Protein Targets Nature Communications Publications on the First X-ray Crystal Structures of Spiegelmers Bound to Protein Targets

Anti-CCL2 and anti-C5a Spiegelmers Revealed in Complex with Their TargetsNOXXON Pharma announced today the publication of two new studies in Nature Communications, entitled:• Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2 • Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer

IBA Signs Formal Contract to Install the First Proton Therapy Center in The Netherlands IBA Signs Formal Contract to Install the First Proton Therapy Center in The Netherlands

IBA (Ion Beam Applications S.A.), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has signed a formal contract with the University Medical Center Groningen (UMCG) to establish the first proton therapy center in The Netherlands, in Groningen.

Are mobile medical apps good for our health? A new study by Research Now reveals that doctors and patients say 'yes' Are mobile medical apps good for our health? A new study by Research Now reveals that doctors and patients say 'yes'

The study looks into the use of mobile health apps and assesses their potential in healthcare. Digital data collection provider, Research Now, spoke to 500 healthcare professionals and 1,000 health app users in the UK.

Scripps Florida Scientists Uncover How Molecule Protects Brain Cells in Parkinson’s Disease Model Scripps Florida Scientists Uncover How Molecule Protects Brain Cells in Parkinson’s Disease Model

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson’s disease.

Drugs to prevent hearing loss expected within 5 years Drugs to prevent hearing loss expected within 5 years

The first drugs to treat hearing conditions could be available by 2020 according to a new report launched today by charity Action on Hearing Loss (formerly RNID).

Brain Training Instead of Medication to Counter Insomnia Brain Training Instead of Medication to Counter Insomnia

The ability to finally enjoy a good night's sleep is something that can be learned. An Austrian Science Fund FWF project has investigated how this can best be learned and who responds best to such "brain training".

Parexel Strengthens Commitment to Global Biopharmaceutical Workforce With New Parexel Academy Programs Parexel Strengthens Commitment to Global Biopharmaceutical Workforce With New Parexel Academy Programs

• Bachelor of Science Degree in Clinical Research offered in Europe• Postgraduate Certificate in Clinical Trial Management offered in North America• Joint Program for Clinical Research and Clinical Trial Management offered in Asia